Stock listing
XXII Stock Price, News, Filings & Events — 22nd Century Group, Inc
Selected listing: XXII · NASDAQ · USD · US
This page tracks 22nd Century Group, Inc's XXII:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following XXII:NASDAQ. XXII:NASDAQ is the stock-level entry point for investors researching 22nd Century Group, Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. 22nd Century Group, Inc. is a public company traded under the ticker XXII in the American market. With a market cap of approximately $1.49 million, the company focuses on developing and commercializing innovative plant-based products. Their primary emphasis is on reducing the harm caused by tobacco and cannabis use.
- Ticker
- XXII:NASDAQ
- Asset type
- Stock
- Market cap
- $2.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
22nd Century Group, Inc XXII:NASDAQ stock context
This page tracks 22nd Century Group, Inc's XXII:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following XXII:NASDAQ. XXII:NASDAQ is the stock-level entry point for investors researching 22nd Century Group, Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. 22nd Century Group, Inc. is a public company traded under the ticker XXII in the American market. With a market cap of approximately $1.49 million, the company focuses on developing and commercializing innovative plant-based products. Their primary emphasis is on reducing the harm caused by tobacco and cannabis use.
Latest news from 22nd Century Group, Inc
22nd Century CEO & Chairman Larry Firestone: Improved Gross Margin, ~5,000 Retail Outlets and >$50B Market Opportunity Highlight Mid-Year...
September 1, 2026
22nd Century Group to Participate in the HC Wainwright Conference on September 15, 2026
August 18, 2026
22nd Century Group Reports Second Quarter 2026 Financial Results
August 13, 2026
22nd Century Group (Nasdaq: XXII) Appoints Katherine Rouse-Bailey as Vice President of Marketing
July 16, 2026
22nd Century Group (Nasdaq: XXII) Launches Pinnacle VLN® Trial in California, Opening Another Major New State for Reduced-Nicotine Cigare...
May 21, 2026
22nd Century Group, Inc earnings calls
22nd Century Group, Inc (XXII) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
22nd Century Group, Inc (XXII) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
22nd Century Group, Inc (XXII) Q4 2025 Earnings Call
March 26, 2026 · Replay with transcript and chapters
22nd Century Group, Inc (XXII) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
22nd Century Group, Inc (XXII) Q2 2025 Earnings Call
August 14, 2025 · Replay with transcript and chapters
22nd Century Group, Inc (XXII) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Research 22nd Century Group, Inc
22nd Century Group, Inc investor report
Review AI stock analysis and investor report context for XXII:NASDAQ.
22nd Century Group, Inc company profile
View the public company page for 22nd Century Group, Inc on 6ix.
22nd Century Group, Inc news
Read company news and market updates connected to 22nd Century Group, Inc.
22nd Century Group, Inc investor events
Find investor webinars, events, and replay context for 22nd Century Group, Inc.